A Study of Single and Multiple Dose Administration of LP-001 in Healthy Subjects

NCT06294275 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

68

Enrollment

INDUSTRY

Sponsor class

Conditions

Myelodysplastic Syndrome (MDS)

Interventions

BIOLOGICAL: LP-001 Dose 1 (Single)
BIOLOGICAL: LP-001 Dose 2 (Single)
BIOLOGICAL: LP-001 Dose 3 (Single)
BIOLOGICAL: LP-001 Dose 4 (Single)
BIOLOGICAL: LP-001 Dose 5 (Single)
BIOLOGICAL: LP-001 Dose 6 (Single)
BIOLOGICAL: Placebo (Single)
BIOLOGICAL: LP-001 Dose 7 (Multiple)
BIOLOGICAL: LP-001 Dose 8 (Multiple)
BIOLOGICAL: Placebo (Multiple)

Sponsor

Longbio Pharma